Pfizer News - PFE

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Pfizer PFE NYSE Ordinary Share
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.17 -0.41% 41.47 41.81 41.25 41.27 41.64 00:00:02
more quote information »

Recent News

Date Time Source Heading
5/16/201913:21DJNFDA Approves Pfizer's Fragmin for Use as a Pediatric..
5/15/201917:01BWPfizer Oncology to Showcase New Data from Innovative Science..
5/15/201907:30DJNPfizer Sees Positive Top-Line Results in Abrocitinib Study
5/15/201907:00GLOBEMatinas BioPharma Announces a Research Collaboration with..
5/15/201906:45BWPfizer Announces Positive Top-Line Results from Phase 3..
5/14/201919:44PRNUSFDA Approves BAVENCIO® (avelumab) Plus INLYTA® (axitinib)..
5/08/201917:45DJNDrug Prices to Be Disclosed in TV Ads Soon -- Update
5/08/201913:38DJNDrug Prices to Be Disclosed in TV Ads Soon
5/08/201909:02DJNPfizer to Buy Rare-Disease Biotech Therachon for Up to $810..
5/08/201907:30DJNPfizer to Buy Rare-Disease Biotech Therachon for Up to $810..
5/08/201906:45BWPfizer Acquires Clinical-Stage Biotech Therachon
5/07/201907:00BWEuropean Commission Approves LORVIQUA® (lorlatinib) for..
5/06/201907:38DJNPfizer Gets FDA Approval for Transthyretin-Mediated..
5/06/201906:45BWU.S. FDA Approves VYNDAQEL® & VYNDAMAX™ for Use in Patients..
4/30/201916:00DJNPfizer Raises Earnings Projections -- Update
4/30/201908:19DJNPfizer Raises Earnings Projections on Biopharma Sales..
4/30/201906:45BWPFIZER REPORTS FIRST-QUARTER 2019 RESULTS
4/26/201912:05DJNPfizer Says EU Regulators Recommend Talzenna be Given..
4/26/201911:00BWPfizer Receives Positive CHMP Opinion for TALZENNA®..
4/25/201911:17BWPfizer Hosts Annual Meeting of Shareholders
4/22/201907:31DJNMerck Gets FDA OK for Keytruda/Inlyta Combo in Renal Cell..
4/18/201917:56DJNPfizer, Lilly Release Top-Line Results From Phase 3 Study of..
4/18/201917:05BWPfizer and Lilly Announce Top-Line Results From Long-Term..
4/18/201915:36DJNPfizer, Johnson & Johnson Weigh on Pharmaceutical ETFs
4/18/201914:00BWPfizer Invites Public to Listen to Webcast of April 25..
4/13/201904:00BWPfizer Announces Presentation of Data from a Phase 2 Study..
4/08/201917:00DJNFDA Approves Two-Drug Combination HIV Treatment
4/04/201915:37DJNFDA Expands Approved Use of Pfizer's Ibrance to Men With..
4/04/201914:57BWU.S. FDA Approves IBRANCE® (palbociclib) for the Treatment..
4/04/201910:04BWAM Best Affirms Credit Ratings of Blue Whale Re Ltd.
4/03/201910:33DJNPfizer Says EC Approves Vizimpro for Non-Small Cell Lung..
4/03/201909:42BWVIZIMPRO® (dacomitinib) Receives Marketing Authorization in..
4/02/201907:00PRNUSSangamo and Pfizer Announce Phase 1/2 Interim Data For..
3/28/201903:00JCNENThe EIU's Index of Cancer Preparedness reveals huge gaps in..
3/27/201908:45NNWAdvanced Medical Technologies Provide Unprecedented..
3/25/201910:53PRNUSS&P 500 Q4 2018 Buybacks Set 4th Consecutive Quarterly..
3/21/201915:22EDGARNotice of Exempt Solicitation. Definitive Material...
3/21/201903:02DJNPfizer Adds to Streak of Deals in Gene Therapies -- WSJ
3/20/201912:53DJNMerck KGaA, Pfizer End Phase III Trial in Previously..
3/20/201907:59DJNPfizer Adds to Big Pharma's Gene-Therapy Deal Streak
3/20/201907:29DJNPfizer Takes 15% Stake in Gene-Therapy Biotech Vivet..
3/20/201906:45BWPfizer Secures Exclusive Option to Acquire Gene Therapy..
3/19/201919:15PRNUSMerck KGaA, Darmstadt, Germany, and Pfizer Announce..
3/19/201910:00BWPfizer Invites Public to View and Listen to Webcast of April..
3/19/201906:39DJNPfizer Unit Recalls Sodium Bicarbonate Injection Lots
3/17/201911:45BWAUGUSTUS Demonstrates Favorable Safety Results of Eliquis®..
3/15/201916:02EDGARConfidential Treatment Order (ct Order)
3/14/201915:14EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
3/14/201915:12EDGARProxy Statement (definitive) (def 14a)
3/11/201919:37BWU.S. FDA Approves Pfizer’s Oncology Biosimilar TRAZIMERA™..
See more news about this stock »


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.